In 2020, the total value of biotech equity financing in Canada, as well as the number of rounds, were slightly higher than in 2019 and the highest since 2016. Canadian companies currently have more than 700 human therapeutics in their pipelines and the country remains one of the strongest life science markets in the world.
This year’s report was compiled in cooperation with our partners – Montreal InVivo, BioAlberta and BIOTECanada.
Would you like to be notified about new reports and other valuable content published by Biotechgate?